Follow The Filings

Farallon Capital Management, L.l.c.

San Francisco, CA 87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

  • $21.7B
  • 77 holdings
  • 2026 Q2
  • +23.6% QoQ
  • Top 5 29.9%

Portfolio

2026 Q2, filed 8/14/2026, top 12 of 77 holdings

Top 5 29.9%, top 10 44.0%

AUM over time

2026 Q2 $21.7B +23.6% QoQ
2021 Q3: $19.7B 2021 Q3: $19.7B
Q3 2021
2021 Q4: $18.7B, −5.1% QoQ 2021 Q4: $18.7B, −5.1% QoQ
Q4
2022 Q1: $18.8B, +0.4% QoQ 2022 Q1: $18.8B, +0.4% QoQ
Q1 2022
2022 Q2: $16.3B, −13.7% QoQ 2022 Q2: $16.3B, −13.7% QoQ
Q2
2022 Q3: $16.8B, +3.5% QoQ 2022 Q3: $16.8B, +3.5% QoQ
Q3
2022 Q4: $15.3B, −9.3% QoQ 2022 Q4: $15.3B, −9.3% QoQ
Q4
2023 Q1: $17.7B, +15.8% QoQ 2023 Q1: $17.7B, +15.8% QoQ
Q1 2023
2023 Q2: $17.9B, +1.3% QoQ 2023 Q2: $17.9B, +1.3% QoQ
Q2
2023 Q3: $20B, +11.5% QoQ 2023 Q3: $20B, +11.5% QoQ
Q3
2023 Q4: $20.1B, +1.0% QoQ 2023 Q4: $20.1B, +1.0% QoQ
Q4
2024 Q1: $22.1B, +9.8% QoQ 2024 Q1: $22.1B, +9.8% QoQ
Q1 2024
2024 Q2: $21.2B, −4.2% QoQ 2024 Q2: $21.2B, −4.2% QoQ
Q2
2024 Q3: $20.4B, −3.6% QoQ 2024 Q3: $20.4B, −3.6% QoQ
Q3
2024 Q4: $19.7B, −3.5% QoQ 2024 Q4: $19.7B, −3.5% QoQ
Q4
2025 Q1: $17.9B, −9.0% QoQ 2025 Q1: $17.9B, −9.0% QoQ
Q1 2025
2025 Q2: $23.2B, +29.2% QoQ 2025 Q2: $23.2B, +29.2% QoQ
Q2
2025 Q3: $24.4B, +5.4% QoQ 2025 Q3: $24.4B, +5.4% QoQ
Q3
2025 Q4: $21.2B, −13.2% QoQ 2025 Q4: $21.2B, −13.2% QoQ
Q4
2026 Q1: $17.5B, −17.2% QoQ 2026 Q1: $17.5B, −17.2% QoQ
Q1 2026
2026 Q2: $21.7B, +23.6% QoQ 2026 Q2: $21.7B, +23.6% QoQ
Q2

Book

2022 Q2 2022 Q1, filed 15 Aug, long equity only

IQV, IQVIA 4.29%, was 3.83% Add +3.1% 3,213,582 $216.99 $697M +96,000 −$24M
TMO, Thermo Fisher Scientific 4.15%, was 3.84% Add +1.5% 1,242,459 $543.28 $675M +18,600 −$48M
TRU, Transunion 3.67%, was 3.40% Add +20.6% 7,462,996 $79.99 $597M +1,274,500 −$43M
BSX, Boston Scientific 3.45%, was 3.70% Reduce −4.4% 15,047,257 $37.27 $561M −693,000 −$136M
ARMK, Aramark 3.02%, was 3.29% Reduce −2.9% 16,008,017 $30.63 $490M −471,781 −$129M
HWM, Howmet Aerospace 2.68%, was 2.60% Add +1.5% 13,837,353 $31.45 $435M +211,000 −$55M
ELV, Elevance Health 2.45%, was 2.01% Add +7.5% 826,482 $482.58 $399M +57,707 +$21M
CNC, Centene 2.26%, was 1.81% Add +7.1% 4,341,194 $84.61 $367M +288,850 +$26M
MA, Mastercard 2.23%, was 2.04% Add +6.9% 1,151,271 $315.48 $363M +74,682 −$22M
YMM, Full Truck Alliance 2.21%, was 0.82% Add +71.2% 39,675,743 $9.06 $359M +16,497,000 +$205M
CLVT, Clarivate 2.09%, was 0.78% Add +181.8% 24,557,800 $13.86 $340M +15,844,372 +$194M
WAB, Wabtec 2.02%, was 2.51% Reduce −18.7% 3,989,933 $82.08 $327M −917,997 −$145M
MSFT, Microsoft 2.01%, was 2.11% Reduce −1.0% 1,272,878 $256.83 $327M −13,200 −$70M
GOOG, Alphabet 1.93%, was 2.49% Reduce −14.5% 143,407 $2,187 $314M −24,400 −$155M
DT, Dynatrace 1.90% New 7,847,000 $39.44 $309M +7,847,000 +$309M
AZNN 1.88%, was 1.26% Add +29.5% 4,629,962 $66.07 $306M +1,053,778 +$69M
CSGP, CoStar Group 1.84% New 4,963,185 $60.41 $300M +4,963,185 +$300M
EFX, Equifax 1.82%, was 1.50% Add +35.6% 1,617,357 $182.78 $296M +424,654 +$13M
CRM, Salesforce 1.79% Add 0.0% 1,758,938 $165.04 $290M +600 −$83M
V, Visa 1.77%, was 1.52% Add +13.2% 1,462,810 $196.89 $288M +170,957 +$1.5M
META, Meta Platforms 1.77%, was 2.44% Reduce −13.7% 1,781,040 $161.25 $287M −283,700 −$172M
ADBE, Adobe 1.60% Add +0.6% 710,772 $366.06 $260M +4,400 −$62M
BX, Blackstone 1.58%, was 1.97% Reduce −3.5% 2,821,451 $91.23 $257M −102,000 −$114M
AON, Aon 1.54%, was 1.75% Reduce −8.4% 928,486 $269.68 $250M −85,500 −$80M
SHW, Sherwin-Williams 1.46%, was 1.62% Reduce −13.3% 1,062,592 $223.91 $238M −162,500 −$68M
NOW, ServiceNow 1.43%, was 1.46% Reduce −0.4% 490,150 $475.52 $233M −2,200 −$41M
EXEL, Exelixis 1.30% Reduce −3.3% 10,174,273 $20.82 $212M −345,788 −$27M
NYT, New York Times 1.18%, was 1.79% Reduce −6.2% 6,880,804 $27.90 $192M −457,550 −$144M
BEKE, KE Holdings 1.10%, was 0.57% Add +14.3% 9,958,500 $17.95 $179M +1,245,000 +$71M
XYZ, Block 1.07% Add +29.3% 2,839,000 $61.46 $174M +643,000 −$123M
AVTR, Avantor 1.01%, was 0.68% Add +38.7% 5,279,464 $31.10 $164M +1,472,352 +$35M
COHR, Coherent 0.95% New 577,982 $266.22 $154M +577,982 +$154M
JAZZ, Jazz Pharmaceuticals 0.88%, was 0.27% Add +179.7% 920,100 $156.01 $144M +591,100 +$92M
Lufax 0.88%, was 0.65% Add +7.7% 23,740,399 $6.00 $142M +1,706,000 +$20M
BEAM, Beam Therapeutics 0.83%, was 0.79% Add +33.8% 3,472,271 $38.71 $134M +877,884 −$14M
Laboratory Corporation Amer 0.75%, was 0.60% Add +20.6% 518,714 $234.36 $122M +88,700 +$8.2M
CVS, CVS Health 0.71%, was 0.64% Add +5.1% 1,246,259 $92.66 $115M +59,976 −$4.6M
ALNY, Alnylam Pharmaceuticals 0.71%, was 0.89% Reduce −23.0% 787,910 $145.85 $115M −235,963 −$52M
SPGI, S&P Global 0.68% New 329,000 $337.06 $111M +329,000 +$111M
UTHR, United Therapeutics 0.57%, was 0.36% Add +3.4% 392,696 $235.64 $93M +13,000 +$24M
TSM, Taiwan Semiconductor 0.57% Add +9.5% 1,126,125 $81.75 $92M +98,000 −$15M
Sarepta Therapeutics 0.55%, was 0.41% Add +19.5% 1,185,051 $74.96 $89M +193,076 +$11M
BRKR, Bruker 0.54%, was 0.36% Add +32.5% 1,406,800 $62.76 $88M +345,000 +$20M
CYTK, Cytokinetics 0.54%, was 0.37% Add +19.3% 2,245,038 $39.29 $88M +362,439 +$19M
ABBV, AbbVie 0.48%, was 0.99% Reduce −55.8% 505,515 $153.16 $77M −639,152 −$108M
INSP, Inspire Medical Systems 0.46%, was 0.39% Add +45.7% 413,000 $182.67 $75M +129,500 +$2.7M
ENTA, Enanta Pharmaceuticals 0.45% Hold 1,550,000 $47.27 $73M — —
RVMD, Revolution Medicines 0.39% Hold 3,250,000 $19.49 $63M — —
PCG, PG&E 0.39% Hold 6,305,142 $9.98 $63M — —
Blueprint Medicines 0.38%, was 0.46% Reduce −10.7% 1,211,987 $50.51 $61M −145,000 −$25M

Showing top 50 of 190 by value

Exits / last held

Gone since 2022 Q1, shown at their last reported size.

Stock % of portfolio Recent activity Shares Reported price* Value Share change $ change
RTX 1.78% Exit 0 $99.07 $335M −3,385,484 −$335M
AVGO, Broadcom 1.37% Exit 0 $629.68 $257M −408,850 −$257M
Zendesk 0.40% Exit 0 $120.29 $76M −630,000 −$76M
Exact Sciences 0.30% Exit 0 $69.92 $56M −802,898 −$56M
DIDIY, Didi Global 0.22% Exit 0 $2.50 $42M −16,868,328 −$42M
RGEN, Repligen 0.22% Exit 0 $188.09 $42M −222,979 −$42M
Mantech International 0.17% Exit 0 $86.19 $32M −375,000 −$32M
VEON, Veoneer 0.08% Exit 0 $36.95 $16M −427,500 −$16M
PACB 0.08% Exit 0 $9.10 $15M −1,631,800 −$15M
Cascade Acquisition 0.05% Exit 0 $10.08 $10M −990,000 −$10M
Holding 0.05% Exit 0 $9.86 $9.9M −1,000,000 −$9.9M
Peoples United Financial 0.05% Exit 0 $19.99 $9.7M −485,000 −$9.7M
Zealand Pharma A/s 0.04% Exit 0 $15.59 $7.7M −496,890 −$7.7M
ARWR, Arrowhead Pharmaceuticals 0.03% Exit 0 $45.99 $6.6M −142,700 −$6.6M
Holding 0.03% Exit 0 $34.64 $5.9M −169,458 −$5.9M
Point Biopharma Global 0.03% Exit 0 $7.97 $5M −626,322 −$5M
Fibrogen 0.02% Exit 0 $12.02 $4.4M −364,764 −$4.4M
Sound Point Acquisition 0.02% Exit 0 $10.06 $3M −300,000 −$3M
Ferro 0.01% Exit 0 $21.74 $2.5M −114,963 −$2.5M
FATE, Fate Therapeutics 0.01% Exit 0 $38.78 $1.2M −31,900 −$1.2M
Holding 0.01% Exit 0 $10.07 $1M −100,000 −$1M
VCYT, Veracyte — Exit 0 $27.57 $896K −32,500 −$896K
CMPX, Compass Therapeutics — Exit 0 $1.37 $798K −582,750 −$798K
Dariohealth — Exit 0 $5.84 $777K −133,083 −$777K
Holding — Exit 0 $1.15 $150K −130,000 −$150K

Weight bar: held both quarters added sold at this quarter’s reported price

* Reported price is value ÷ shares from the 13F as of period end, not a live market quote. Weight % is each long-equity position ÷ full 13F AUM, so rows may not sum to 100% when the filing includes options or other non-equity (excluded from this table). Share change and $ change are vs 2022 Q1. Click a column header to sort, or New, Hold, Add or Reduce to bring those moves to the top. Exit opens the last-held block below.

Filings history

20 periods, with AUM normalized

Period Holds AUM QoQ Form Filed Filing ID
2026 Q2 89 $21.7B +23.6% 13F-HR 8/14/2026 000090883426000432
2026 Q1 1 $1.5B — new holds 8/14/2026 000090883426000434
2026 Q1 172 $17.5B −17.2% 13F-HR 5/15/2026 000090883426000240
2025 Q4 1 $1B — new holds 8/14/2026 000090883426000433
2025 Q4 2 $884M — new holds 5/15/2026 000090883426000241
2025 Q4 151 $21.2B −13.2% 13F-HR 2/17/2026 000090883426000087
2025 Q3 144 $24.4B — RESTATEMENT 2/17/2026 000090883426000086
2025 Q3 144 $24.4B +5.4% 13F-HR 11/14/2025 000090883425000353
2025 Q2 1 $140M — new holds 2/17/2026 000090883426000085
2025 Q2 3 $483M — new holds 11/14/2025 000090883425000352
2025 Q2 141 $23.2B +29.2% 13F-HR 8/14/2025 000090883425000248
2025 Q1 1 $274M — new holds 2/17/2026 000090883426000084
2025 Q1 3 $416M — new holds 11/14/2025 000090883425000351
2025 Q1 7 $2.2B — new holds 8/14/2025 000090883425000247
2025 Q1 135 $17.9B −9.0% 13F-HR 5/15/2025 000090883425000177
2024 Q4 1 $85M — new holds 2/17/2026 000090883426000083
2024 Q4 2 $349M — new holds 11/14/2025 000090883425000350
2024 Q4 6 $2.3B — new holds 8/14/2025 000090883425000246
2024 Q4 4 $333M — new holds 5/15/2025 000090883425000180
2024 Q4 138 $19.7B −3.5% 13F-HR 2/14/2025 000090883425000081
2024 Q3 1 $145M — new holds 11/14/2025 000090883425000349
2024 Q3 6 $1.5B — new holds 8/14/2025 000090883425000243
2024 Q3 3 $216M — new holds 5/15/2025 000090883425000179
2024 Q3 2 $544M — new holds 2/14/2025 000090883425000080
2024 Q3 153 $20.4B −3.6% 13F-HR 11/14/2024 000090883424000307
2024 Q2 1 $120M — new holds 11/14/2025 000090883425000348
2024 Q2 5 $1.2B — new holds 8/14/2025 000090883425000245
2024 Q2 1 $199M — new holds 5/15/2025 000090883425000178
2024 Q2 2 $452M — new holds 2/14/2025 000090883425000079
2024 Q2 1 $149M — new holds 11/14/2024 000090883424000324
2024 Q2 157 $21.2B −4.2% 13F-HR 8/14/2024 000090883424000200
2024 Q1 1 $93M — new holds 11/14/2025 000090883425000347
2024 Q1 4 $1.2B — new holds 8/14/2025 000090883425000244
2024 Q1 2 $159M — new holds 2/14/2025 000090883425000078
2024 Q1 1 $45M — new holds 8/14/2024 000090883424000202
2024 Q1 167 $22.1B — RESTATEMENT 5/24/2024 000090883424000159
2024 Q1 167 $22.1B +9.8% 13F-HR 5/15/2024 000090883424000135
2023 Q4 1 $65M — new holds 11/14/2025 000090883425000346
2023 Q4 2 $548M — new holds 8/14/2025 000090883425000250
2023 Q4 5 $1.1B — new holds 5/15/2024 000090883424000141
2023 Q4 150 $20.1B +1.0% 13F-HR 2/14/2024 000090883424000070
2023 Q3 1 $40M — new holds 11/14/2025 000090883425000345
2023 Q3 1 $40M — new holds 5/15/2024 000090883424000138
2023 Q3 2 $1.4B — new holds 2/14/2024 000090883424000077
2023 Q3 1 $1.9B — new holds 2/12/2024 000090883424000049
2023 Q3 159 $20B +11.5% 13F-HR 11/14/2023 000090883423000150
2023 Q2 2 $669M — new holds 2/14/2024 000090883424000076
2023 Q2 5 $1.4B — new holds 11/14/2023 000090883423000157
2023 Q2 1 $1.2B — new holds 10/26/2023 000090883423000134
2023 Q2 165 $17.9B +1.3% 13F-HR 8/14/2023 000090883423000109
2023 Q1 2 $234M — new holds 2/14/2024 000090883424000075
2023 Q1 3 $389M — new holds 11/14/2023 000090883423000156
2023 Q1 1 $15M — new holds 8/14/2023 000090883423000110
2023 Q1 187 $17.7B +15.8% 13F-HR 5/15/2023 000117570723000127
2022 Q4 1 $171M — new holds 2/14/2024 000090883424000074
2022 Q4 3 $485M — new holds 11/14/2023 000090883423000155
2022 Q4 7 $1B — new holds 5/15/2023 000117570723000136
2022 Q4 232 $15.3B −9.3% 13F-HR 2/14/2023 000117570723000051
2022 Q3 1 $125M — new holds 2/14/2024 000090883424000073
2022 Q3 3 $415M — new holds 11/14/2023 000090883423000154
2022 Q3 5 $411M — new holds 5/15/2023 000117570723000135
2022 Q3 4 $434M — new holds 2/14/2023 000090966123000005
2022 Q3 298 $16.8B +3.5% 13F-HR 11/14/2022 000156761922019851
2022 Q2 1 $115M — new holds 2/14/2024 000090883424000081
2022 Q2 3 $411M — new holds 11/14/2023 000090883423000153
2022 Q2 2 $337M — new holds 5/15/2023 000117570723000134
2022 Q2 3 $136M — new holds 2/14/2023 000090966123000003
2022 Q2 9 $1.2B — new holds 11/14/2022 000156761922019862
2022 Q2 297 $16.3B −13.7% 13F-HR 8/15/2022 000156761922015953
2022 Q1 1 $268M — new holds 11/14/2023 000090883423000152
2022 Q1 1 $314M — new holds 5/15/2023 000117570723000133
2022 Q1 1 $27M — new holds 2/14/2023 000090966123000002
2022 Q1 3 $186M — new holds 11/14/2022 000156761922019864
2022 Q1 8 $1.1B — new holds 8/15/2022 000156761922015972
2022 Q1 307 $18.8B +0.4% 13F-HR 5/16/2022 000156761922010736
2021 Q4 1 $227M — new holds 5/15/2023 000117570723000132
2021 Q4 1 $7M — new holds 11/14/2022 000156761922019852
2021 Q4 1 $115M — new holds 8/15/2022 000156761922015968
2021 Q4 2 $98M — new holds 5/19/2022 000156761922011257
2021 Q4 6 $833M — new holds 5/16/2022 000156761922010757
2021 Q4 289 $18.7B −5.1% 13F-HR 2/14/2022 000156761922003965
2021 Q3 1 $182M — new holds 5/15/2023 000117570723000131
2021 Q3 1 $105M — new holds 8/15/2022 000156761922015964
2021 Q3 1 $57M — new holds 5/19/2022 000156761922011256
2021 Q3 3 $998M — new holds 5/16/2022 000156761922010753
2021 Q3 2 $344M — new holds 2/14/2022 000156761922003981
2021 Q3 293 $19.7B — 13F-HR 11/15/2021 000095012321015168

About

Farallon Capital Management, L.l.c.

87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

SEC filing name
FARALLON CAPITAL MANAGEMENT, L.L.C.
Location
San Francisco, CA
All SEC filings
View on sec.gov